100 related articles for article (PubMed ID: 28866057)
1. Mitochondrial disruption in peroxisome deficient cells is hepatocyte selective but is not mediated by common hepatic peroxisomal metabolites.
Shinde AB; Baboota RK; Denis S; Loizides-Mangold U; Peeters A; Espeel M; Malheiro AR; Riezman H; Vinckier S; Vaz FM; Brites P; Ferdinandusse S; Van Veldhoven PP; Baes M
Mitochondrion; 2018 Mar; 39():51-59. PubMed ID: 28866057
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria in peroxisome-deficient hepatocytes exhibit impaired respiration, depleted DNA, and PGC-1α independent proliferation.
Peeters A; Shinde AB; Dirkx R; Smet J; De Bock K; Espeel M; Vanhorebeek I; Vanlander A; Van Coster R; Carmeliet P; Fransen M; Van Veldhoven PP; Baes M
Biochim Biophys Acta; 2015 Feb; 1853(2):285-98. PubMed ID: 25450972
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse).
Baumgart E; Vanhorebeek I; Grabenbauer M; Borgers M; Declercq PE; Fahimi HD; Baes M
Am J Pathol; 2001 Oct; 159(4):1477-94. PubMed ID: 11583975
[TBL] [Abstract][Full Text] [Related]
4. Beta-oxidation in hepatocyte cultures from mice with peroxisomal gene knockouts.
Dirkx R; Meyhi E; Asselberghs S; Reddy J; Baes M; Van Veldhoven PP
Biochem Biophys Res Commun; 2007 Jun; 357(3):718-23. PubMed ID: 17442273
[TBL] [Abstract][Full Text] [Related]
5. Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities.
Dirkx R; Vanhorebeek I; Martens K; Schad A; Grabenbauer M; Fahimi D; Declercq P; Van Veldhoven PP; Baes M
Hepatology; 2005 Apr; 41(4):868-78. PubMed ID: 15732085
[TBL] [Abstract][Full Text] [Related]
6. [Peroxisomal beta-oxidation].
Mannaerts GP; Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
[TBL] [Abstract][Full Text] [Related]
7. Altered mitochondrial and peroxisomal integrity in lipocalin-2-deficient mice with hepatic steatosis.
Asimakopoulou A; Fülöp A; Borkham-Kamphorst E; de Leur EV; Gassler N; Berger T; Beine B; Meyer HE; Mak TW; Hopf C; Henkel C; Weiskirchen R
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2093-2110. PubMed ID: 28396286
[TBL] [Abstract][Full Text] [Related]
8. Degradation of very long chain dicarboxylic polyunsaturated fatty acids in mouse hepatocytes, a peroxisomal process.
Nguyen SD; Baes M; Van Veldhoven PP
Biochim Biophys Acta; 2008 Aug; 1781(8):400-5. PubMed ID: 18619556
[TBL] [Abstract][Full Text] [Related]
9. Failure of microtubule-mediated peroxisome division and trafficking in disorders with reduced peroxisome abundance.
Nguyen T; Bjorkman J; Paton BC; Crane DI
J Cell Sci; 2006 Feb; 119(Pt 4):636-45. PubMed ID: 16449325
[TBL] [Abstract][Full Text] [Related]
10. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
11. A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3.
Ferdinandusse S; Jimenez-Sanchez G; Koster J; Denis S; Van Roermund CW; Silva-Zolezzi I; Moser AB; Visser WF; Gulluoglu M; Durmaz O; Demirkol M; Waterham HR; Gökcay G; Wanders RJ; Valle D
Hum Mol Genet; 2015 Jan; 24(2):361-70. PubMed ID: 25168382
[TBL] [Abstract][Full Text] [Related]
12. Zellweger syndrome knockout mouse models challenge putative peroxisomal beta-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis.
Infante JP; Huszagh VA
Mol Genet Metab; 2001 Jan; 72(1):1-7. PubMed ID: 11161822
[TBL] [Abstract][Full Text] [Related]
13. Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice.
Keane MH; Overmars H; Wikander TM; Ferdinandusse S; Duran M; Wanders RJ; Faust PL
Hepatology; 2007 Apr; 45(4):982-97. PubMed ID: 17393522
[TBL] [Abstract][Full Text] [Related]
14. Hepatic dysfunction in peroxisomal disorders.
Baes M; Van Veldhoven PP
Biochim Biophys Acta; 2016 May; 1863(5):956-70. PubMed ID: 26453805
[TBL] [Abstract][Full Text] [Related]
15. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance.
Noland RC; Woodlief TL; Whitfield BR; Manning SM; Evans JR; Dudek RW; Lust RM; Cortright RN
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E986-E1001. PubMed ID: 17638705
[TBL] [Abstract][Full Text] [Related]
16. Unbalanced lipolysis results in lipotoxicity and mitochondrial damage in peroxisome-deficient
Bülow MH; Wingen C; Senyilmaz D; Gosejacob D; Sociale M; Bauer R; Schulze H; Sandhoff K; Teleman AA; Hoch M; Sellin J
Mol Biol Cell; 2018 Feb; 29(4):396-407. PubMed ID: 29282281
[TBL] [Abstract][Full Text] [Related]
17. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of PGC-1α increases peroxisomal activity and mitochondrial fatty acid oxidation in human primary myotubes.
Huang TY; Zheng D; Houmard JA; Brault JJ; Hickner RC; Cortright RN
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E253-E263. PubMed ID: 28073778
[TBL] [Abstract][Full Text] [Related]
19. Induction of peroxisomal changes in oligodendrocytes treated with 7-ketocholesterol: Attenuation by α-tocopherol.
Nury T; Sghaier R; Zarrouk A; Ménétrier F; Uzun T; Leoni V; Caccia C; Meddeb W; Namsi A; Sassi K; Mihoubi W; Riedinger JM; Cherkaoui-Malki M; Moreau T; Vejux A; Lizard G
Biochimie; 2018 Oct; 153():181-202. PubMed ID: 30031877
[TBL] [Abstract][Full Text] [Related]
20. Neocortical and cerebellar developmental abnormalities in conditions of selective elimination of peroxisomes from brain or from liver.
Krysko O; Hulshagen L; Janssen A; Schütz G; Klein R; De Bruycker M; Espeel M; Gressens P; Baes M
J Neurosci Res; 2007 Jan; 85(1):58-72. PubMed ID: 17075904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
